查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1961079

數位醫藥供應鏈管理市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、交付模式、軟體模組、地區和競爭對手分類，2021-2031年

Digital Pharmaceutical Supply Chain Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Mode of Delivery, By Software Modules, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球數位醫藥供應鏈管理市場預計將從 2025 年的 9.5001 億美元成長到 2031 年的 14.0268 億美元，複合年成長率為 6.71%。

在這一領域，物聯網 (IoT)、區塊鏈和人工智慧 (AI) 等技術被整合起來，用於管理從生產到交付的藥品物流，確保即時可視性和產品完整性。推動成長的關鍵因素包括嚴格的監管要求，例如對追蹤和溯源合規性的要求，以及對溫度敏感生物製藥維持低溫運輸的迫切需求。此外，降低營運成本和消除供應鏈中的假藥也是推動產業發展的重要因素，使得這些先進的數位化解決方案對於確保病患安全和提高效率至關重要。

市場概覽
預測期 2027-2031
市場規模：2025年 950,010,000 美元
市場規模：2031年 14.0268億美元
複合年成長率：2026-2031年 6.71%
成長最快的細分市場 軟體
最大的市場 北美洲

然而，市場成長常常受到高昂的實施成本以及將現代數位工具與現有傳統基礎設施整合困難的限制，導致互通性方面存在重大挑戰。儘管存在這些障礙，但該領域仍在不斷努力推進技術進步，以應對日益成長的業務量和複雜性。根據醫療保健分銷聯盟研究基金會（Healthcare Distribution Alliance Research Foundation）預測，到2024年，68%的藥品分銷公司將採用自動化方法，一半的發票將透過這些數位化系統處理。這項數據表明，企業越來越依賴數位自動化來支援業務流程。

市場促進因素

為緩解全球藥品短缺，對具有韌性的供應鏈的需求是推動數位化管理系統普及的主要動力。儘管面臨物流中斷和原料短缺，但確保患者照護的連續性仍然至關重要，這促使相關人員實施即時監控和預測分析，以識別薄弱環節並高效管理存量基準。根據美國衛生系統藥劑師協會於2024年4月發布的《全國藥品短缺統計數據》，2024年第一季藥品短缺數量達到創紀錄的323種，凸顯了強大的數位化監控對於應對這些供應缺口的重要性。

隨著假藥氾濫日益嚴重，採用先進的認證技術來保障藥品的完整性變得愈發必要。製藥公司正利用序列化工具和區塊鏈技術來保護從生產到終端用戶的整個控制鏈，並檢驗藥品的真偽，從而確保患者獲得正品藥品，並維護公眾健康。根據製藥安全研究所 (PSI) 2024 年 6 月發布的《2023 年現況報告》，該研究所記錄了 2023 年發生的 6,659 起藥品犯罪案件，顯示藥品犯罪構成持續威脅，而數位追蹤技術必須應對這一威脅。這種以安全為中心的策略與更廣泛的投資趨勢相符。根據三菱重工 (MHI) 2024 年的調查，55% 的供應鏈經理表示將增加對供應鏈技術和創新的投資，這反映出全國對數位轉型的重視。

市場挑戰

將現有傳統基礎設施與現代數位工具整合是全球數位化醫藥供應鏈管理市場擴張的一大障礙。醫藥行業的許多相關人員仍然依賴分散且過時的系統，這些系統缺乏與人工智慧驅動的分析和區塊鏈等先進平台無縫整合的柔軟性。這種互通性差距造成了資料孤島，將關鍵的醫藥物流資訊困在孤立的部門中，阻礙了高效運作所需的全面、即時可視性。因此，企業在嘗試維修這些傳統系統時會面臨嚴重的延誤和增加的財務負擔，直接阻礙了全面數位化供應鏈解決方案的普及。

這些技術壁壘的影響也反映在近期產業關於營運透明度的數據中。據GS1美國公司稱，到2025年，約43%的供應鏈專業人士表示難以維持全面的營運可視性，這凸顯了在整個網路中充分利用標準化數位資料的現狀依然存在。這種透明度的缺失不僅削弱了數位化帶來的效率提升，也使企業難以滿足嚴格的可追溯性要求。只要這些整合難題持續存在，市場充分實現自動化和產品完整性提升所帶來的益處的能力就將受到限制。

市場趨勢

將數位雙胞胎技術引入供應鏈仿真，使製藥公司能夠從靜態分析轉向動態虛擬場景規劃，從而製定更有效的物流策略。透過產生實體供應鏈的精確虛擬副本，相關人員可以模擬潛在中斷的影響，測試新的配送路線，並在不影響實際庫存的情況下檢驗流程變更。這項功能在最佳化複雜的網路設計方面尤其重要，因為實體試驗極為高成本。根據Hexagon於2025年3月發布的《製藥製造轉型》報告，只有17%的公司表示目前正在使用其設施的數位雙胞胎，而79%的公司正在新計畫中利用該技術來加強協作並提高設計精度。

同時，人工智慧 (AI) 在預測分析和需求預測方面的應用，正透過優先提升商業效率和減少廢棄物，變革庫存管理。與傳統的被動式模型不同，這些先進的演算法能夠分析大量的歷史數據和即時數據，從而預測市場消費模式。這確保了對溫度敏感的生物製藥能夠妥善保管，最大限度地降低過期風險。這一趨勢正透過自動化決策，推動實際的投資回報 (ROI)，其重點在於最佳化營運資本和服務水準之間的平衡。根據 LogiPharma 發布的《2024 年 LogiPharma AI 報告》（2024 年 11 月），40% 的醫藥供應鏈領導者目前正優先考慮採用 AI 技術進行需求預測和減少廢棄物，這標誌著企業正朝著數據驅動的營運效率方向邁出重要一步。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球數位化醫藥供應鏈管理市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品（軟體、硬體）分類
    • 交付方式（本地部署、雲端部署、Web部署）
    • 軟體模組（計劃與分析、採購、製造、物流、庫存管理）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美數位化醫藥供應鏈管理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲數位化醫藥供應鏈管理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區數位化醫藥供應鏈管理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲數位化醫藥供應鏈管理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲數位化醫藥供應鏈管理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球數位化醫藥供應鏈管理市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • McKesson Corporation
  • Mediceo Corporation
  • Palantir Technologies, Inc.
  • InterSystems Corporation
  • Tecsys Inc.
  • Oracle Corporation
  • SAP SE
  • Infor Inc.
  • CenTrak, Inc.（HALMA plc）
  • Terso Solutions, Inc.（Promega Corporation）

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23401

The Global Digital Pharmaceutical Supply Chain Management Market is projected to expand from USD 950.01 Million in 2025 to USD 1402.68 Million by 2031, registering a CAGR of 6.71%. This sector integrates technologies such as the Internet of Things, blockchain, and artificial intelligence to oversee medication logistics from manufacturing through delivery, ensuring real-time visibility and product integrity. Growth is primarily driven by strict regulatory mandates for track-and-trace compliance and the critical requirement to maintain cold chains for temperature-sensitive biologics. Additionally, the industry is motivated by the need to lower operational costs and eradicate counterfeit drugs from the supply network, necessitating these advanced digital solutions to guarantee patient safety and efficiency.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 950.01 Million
Market Size 2031USD 1402.68 Million
CAGR 2026-20316.71%
Fastest Growing SegmentSoftware
Largest MarketNorth America

However, market growth is frequently hindered by high deployment costs and the difficulty of merging modern digital tools with existing legacy infrastructures, which results in significant interoperability challenges. Despite these obstacles, the sector remains committed to technological advancement to manage increasing volume and complexity. According to the Healthcare Distribution Alliance Research Foundation, in 2024, 68 percent of pharmaceutical distribution companies reported using automated methods, with half of all invoice lines processed through these digitized systems. This statistic highlights the increasing reliance on digital automation to support operational workflows.

Market Driver

The demand for resilient supply chains to mitigate global drug shortages serves as a major catalyst for the adoption of digital management systems. Industry stakeholders are implementing real-time monitoring and predictive analytics to spot vulnerabilities and efficiently manage inventory levels, driven by the urgent need to ensure continuity in patient care despite logistical disruptions and raw material scarcity. According to the American Society of Health-System Pharmacists, April 2024, in the 'National Drug Shortages Statistics', active drug shortages hit a record high of 323 in the first quarter of 2024, emphasizing the critical necessity for robust digital oversight to navigate these supply gaps.

The increasing prevalence of counterfeit drugs further necessitates advanced authentication technologies to guarantee product integrity. Pharmaceutical entities employ serialization tools and blockchain to secure the chain of custody and verify authenticity from production to the end user, ensuring patients receive genuine medications and protecting public health. According to the Pharmaceutical Security Institute, June 2024, in the '2023 Situation Report', the organization recorded 6,659 pharmaceutical crime incidents in 2023, representing a persistent threat that digital tracking seeks to neutralize. This security focus aligns with broader investment trends; according to MHI, in 2024, 55 percent of supply chain leaders reported increasing their financial investment in supply chain technology and innovation, reflecting an industry-wide commitment to digital transformation.

Market Challenge

The integration of modern digital tools with existing legacy infrastructures poses a significant barrier to the expansion of the Global Digital Pharmaceutical Supply Chain Management Market. Many stakeholders in the pharmaceutical industry continue to rely on fragmented, older systems that lack the flexibility to communicate seamlessly with advanced platforms such as AI-driven analytics or blockchain. This interoperability gap creates data silos where critical medication logistics information becomes trapped within isolated departments, preventing the holistic, real-time visibility necessary for efficient operations. Consequently, companies encounter significant delays and increased financial burdens when attempting to retrofit these archaic structures, which directly curbs the adoption rate of comprehensive digital supply chain solutions.

The impact of these technological hurdles is reflected in recent industry data concerning operational transparency. According to GS1 US, in 2025, nearly 43 percent of supply chain professionals reported struggling to maintain full visibility into their operations, highlighting a persistent inability to fully leverage standardized digital data across the network. This lack of transparency not only undermines the efficiency gains promised by digitization but also complicates compliance with rigorous track-and-trace mandates. As long as these integration complexities persist, the market's ability to fully realize the benefits of automation and enhanced product integrity will remain constrained.

Market Trends

The adoption of Digital Twin Technology for Supply Chain Simulation allows pharmaceutical companies to strategize logistics by transitioning from static analysis to dynamic, virtual scenario planning. By generating exact virtual replicas of the physical supply chain, stakeholders can simulate the impact of potential disruptions, test new distribution routes, and validate process changes without risking actual inventory. This capability is particularly vital for optimizing complex network designs where physical trial-and-error is prohibitively expensive. According to Hexagon, March 2025, in the 'Transforming Pharmaceutical Manufacturing' report, while only 17 percent of respondents reported currently using a digital twin of their facilities, 79 percent are now leveraging the technology for new projects to enhance collaboration and design precision.

Simultaneously, the integration of Artificial Intelligence for Predictive Analytics and Demand Forecasting is reshaping inventory management by prioritizing commercial efficiency and waste reduction. Unlike traditional reactive models, these advanced algorithms analyze vast historical and real-time datasets to predict market consumption patterns, ensuring that temperature-sensitive biologics are positioned to minimize expiration risks. This trend focuses heavily on optimizing the balance between working capital and service levels, driving tangible returns on investment through automated decision-making. According to LogiPharma, November 2024, in the '2024 LogiPharma AI Report', 40 percent of pharmaceutical supply chain leaders are now prioritizing AI specifically for demand forecasting and minimizing waste, marking a decisive move towards data-driven operational excellence.

Key Market Players

  • McKesson Corporation
  • Mediceo Corporation
  • Palantir Technologies, Inc.
  • InterSystems Corporation
  • Tecsys Inc.
  • Oracle Corporation
  • SAP SE
  • Infor Inc.
  • CenTrak, Inc. (HALMA plc)
  • Terso Solutions, Inc. (Promega Corporation)

Report Scope

In this report, the Global Digital Pharmaceutical Supply Chain Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Pharmaceutical Supply Chain Management Market, By Product

  • Software
  • Hardware

Digital Pharmaceutical Supply Chain Management Market, By Mode of Delivery

  • On-premises
  • Cloud-based
  • Web-based

Digital Pharmaceutical Supply Chain Management Market, By Software Modules

  • Planning & Analytics
  • Procurement
  • Manufacturing
  • Logistics
  • Inventory management

Digital Pharmaceutical Supply Chain Management Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Pharmaceutical Supply Chain Management Market.

Available Customizations:

Global Digital Pharmaceutical Supply Chain Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Digital Pharmaceutical Supply Chain Management Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Software, Hardware)
    • 5.2.2. By Mode of Delivery (On-premises, Cloud-based, Web-based)
    • 5.2.3. By Software Modules (Planning & Analytics, Procurement, Manufacturing, Logistics, Inventory management)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Digital Pharmaceutical Supply Chain Management Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Mode of Delivery
    • 6.2.3. By Software Modules
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Digital Pharmaceutical Supply Chain Management Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Mode of Delivery
        • 6.3.1.2.3. By Software Modules
    • 6.3.2. Canada Digital Pharmaceutical Supply Chain Management Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Mode of Delivery
        • 6.3.2.2.3. By Software Modules
    • 6.3.3. Mexico Digital Pharmaceutical Supply Chain Management Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Mode of Delivery
        • 6.3.3.2.3. By Software Modules

7. Europe Digital Pharmaceutical Supply Chain Management Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Mode of Delivery
    • 7.2.3. By Software Modules
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Digital Pharmaceutical Supply Chain Management Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Mode of Delivery
        • 7.3.1.2.3. By Software Modules
    • 7.3.2. France Digital Pharmaceutical Supply Chain Management Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Mode of Delivery
        • 7.3.2.2.3. By Software Modules
    • 7.3.3. United Kingdom Digital Pharmaceutical Supply Chain Management Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Mode of Delivery
        • 7.3.3.2.3. By Software Modules
    • 7.3.4. Italy Digital Pharmaceutical Supply Chain Management Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Mode of Delivery
        • 7.3.4.2.3. By Software Modules
    • 7.3.5. Spain Digital Pharmaceutical Supply Chain Management Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Mode of Delivery
        • 7.3.5.2.3. By Software Modules

8. Asia Pacific Digital Pharmaceutical Supply Chain Management Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Mode of Delivery
    • 8.2.3. By Software Modules
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Digital Pharmaceutical Supply Chain Management Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Mode of Delivery
        • 8.3.1.2.3. By Software Modules
    • 8.3.2. India Digital Pharmaceutical Supply Chain Management Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Mode of Delivery
        • 8.3.2.2.3. By Software Modules
    • 8.3.3. Japan Digital Pharmaceutical Supply Chain Management Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Mode of Delivery
        • 8.3.3.2.3. By Software Modules
    • 8.3.4. South Korea Digital Pharmaceutical Supply Chain Management Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Mode of Delivery
        • 8.3.4.2.3. By Software Modules
    • 8.3.5. Australia Digital Pharmaceutical Supply Chain Management Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Mode of Delivery
        • 8.3.5.2.3. By Software Modules

9. Middle East & Africa Digital Pharmaceutical Supply Chain Management Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Mode of Delivery
    • 9.2.3. By Software Modules
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Digital Pharmaceutical Supply Chain Management Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Mode of Delivery
        • 9.3.1.2.3. By Software Modules
    • 9.3.2. UAE Digital Pharmaceutical Supply Chain Management Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Mode of Delivery
        • 9.3.2.2.3. By Software Modules
    • 9.3.3. South Africa Digital Pharmaceutical Supply Chain Management Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Mode of Delivery
        • 9.3.3.2.3. By Software Modules

10. South America Digital Pharmaceutical Supply Chain Management Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Mode of Delivery
    • 10.2.3. By Software Modules
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Digital Pharmaceutical Supply Chain Management Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Mode of Delivery
        • 10.3.1.2.3. By Software Modules
    • 10.3.2. Colombia Digital Pharmaceutical Supply Chain Management Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Mode of Delivery
        • 10.3.2.2.3. By Software Modules
    • 10.3.3. Argentina Digital Pharmaceutical Supply Chain Management Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Mode of Delivery
        • 10.3.3.2.3. By Software Modules

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Digital Pharmaceutical Supply Chain Management Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. McKesson Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Mediceo Corporation
  • 15.3. Palantir Technologies, Inc.
  • 15.4. InterSystems Corporation
  • 15.5. Tecsys Inc.
  • 15.6. Oracle Corporation
  • 15.7. SAP SE
  • 15.8. Infor Inc.
  • 15.9. CenTrak, Inc. (HALMA plc)
  • 15.10. Terso Solutions, Inc. (Promega Corporation)

16. Strategic Recommendations

17. About Us & Disclaimer